ArticlePathology oncology research : POR2019

Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer.

Jianying Jin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.